11Jun 2023
ABO Blood Group and Bleeding and Survival in VA-ECMO Patients

ABO Blood Group and Bleeding and Survival in VA-ECMO Patients

A study examined the relationship between blood type and transfusion requirements in patients undergoing extracorporeal membrane oxygenation (ECMO) treatment. The research involved 307 patients at a referral hospital. The distribution of blood groups included 40% group O, 40% group A, 14% group B, and 6% group AB. The study found that there was no statistically significant difference in transfusion requirements for packed red blood cells, fresh frozen plasma, and platelets among the blood groups. However, there was a significant difference in cryoprecipitate usage, with group AB requiring the most. Additionally, a longer duration of ECMO treatment was associated with increased blood product usage. The mortality rates at 30 days and 1 year did not show significant differences among the blood groups.

  • #critical care

Like

Save

Share